All lobbying filings

W Strategies, LLC

W Strategies, LLC filed a Q2 report for Astrazeneca Pharmaceuticals LP on July 20, 2026, reporting $80,000 in lobbying income.

Lobbying for Astrazeneca Pharmaceuticals LP · Biopharmaceutical Company.

As filed: W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP.

All filings by W Strategies, LLC · Everything Astrazeneca Pharmaceuticals LP has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Delaware

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues around drug pricing. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Education about 340b program.

Bills named in this filing 1

H.R. 946
ORPHAN Cures Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.